EUVIMEDEUVIMED entdecken
Crossref

Esketamine Implementation Challenges in Psychiatry: A Qualitative Analysis of Mental Healthcare Providers’ Social Media Commentary

Brian S. Barnett

Annals of Clinical Psychiatry · 2026-05 · 37 (2) · 62-70

DOI: 10.1177/10401237261434394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Psychiatry, online erschienen am 10.03.2026. Verfasst von Brian S. Barnett. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Though esketamine was approved by the Food and Drug Administration (FDA) for treatment-resistant depression in 2019, there is no published research on implementation challenges. Therefore, the aim of this study was to investigate online commentary about these challenges among mental healthcare providers.

Methods

Using the terms “esketamine” and “Spravato”, the author searched social media groups dedicated to mental healthcare providers on December 15, 2022. Posts and associated comments about using or implementing esketamine into practices were included in the dataset and thematically coded. Prevalence of themes about implementation challenges, illustrative quotes, and sentiment analyses are reported.

Results

186 relevant posts and comments from March 12, 2019 to November 27, 2022 were identified. The most discussed challenges were billing/reimbursement (65.1%), billing codes (48.9%), staffing (18.3%), pharmacy/drug procurement (16.7%), space (11.8%), time (10.2%), “Buy and bill” acquisition (9.1%), and the FDA Risk Evaluation and Mitigation Strategy (REMS) program (7%). Sentiment regarding reimbursement for esketamine was mostly negative [72.3% (34/47 posts)], as was sentiment towards esketamine’s manufacturer (62.5% (5/8 posts). Most posts [86.7% (13/15 posts)] comparing esketamine to ketamine favored using ketamine.

Conclusions

These data suggest that under-reimbursement, billing challenges, and logistical barriers may be hamstringing implementation of esketamine into psychiatric practices.

Zitieren

APA

Barnett, B. S. (2026). Esketamine Implementation Challenges in Psychiatry: A Qualitative Analysis of Mental Healthcare Providers’ Social Media Commentary. Annals of Clinical Psychiatry, 37(2), 62-70. https://doi.org/10.1177/10401237261434394

Vancouver

Barnett BS. Esketamine Implementation Challenges in Psychiatry: A Qualitative Analysis of Mental Healthcare Providers’ Social Media Commentary. Annals of Clinical Psychiatry. 2026;37(2):62-70. doi:10.1177/10401237261434394

BibTeX
@article{Barnett2026,
  author = {Barnett, Brian S.},
  title = {Esketamine Implementation Challenges in Psychiatry: A Qualitative Analysis of Mental Healthcare Providers’ Social Media Commentary},
  journal = {Annals of Clinical Psychiatry},
  year = {2026},
  volume = {37},
  number = {2},
  pages = {62--70},
  doi = {10.1177/10401237261434394}
}
Kostenlos starten →